SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, today announced the completion of its Series C financing, ...
Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS & DALY CITY, Calif.--(BUSINESS WIRE)--DNA ...
DNA Script, a pioneer in DNA synthesis providing scientists with rapid, on-demand access to high-quality DNA, today announced it has signed distribution agreements with Gencell, Bio-Medical Science Co ...
DNA Script, a pioneer in Enzymatic DNA Synthesis (EDS) for on-demand DNA printing, recently announced the completion of its Series C financing, raising $200 million of new capital. With this latest ...
DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access ...
DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...
The MarketWatch News Department was not involved in the creation of this content. -- Enables researchers worldwide to access high-quality ssDNA oligonucleotides within hours -- Establishes direct ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results